Mizar Therapeutics is a biotechnology company that develops drugs using live-cell, single-molecule imaging and machine-learning technology.
Mizar Therapeutics has raised $519K in total funding. The most recent round was Undisclosed. The last funding was announced in June 2025.
Mizar Therapeutics is headquartered in Woods Hole, United States.
Mizar Therapeutics is a biotechnology company that develops drugs using live-cell, single-molecule imaging and machine-learning technology.
Mizar Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mizar Therapeutics — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/mizar-therapeutics. Accessed November 14, 2026.
VCBacked. (2025). Mizar Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/mizar-therapeutics
{{cite web |title=Mizar Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mizar-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Mizar Therapeutics? Request a listing update